rs2280869
Positions:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_001205293.3(CACNA1E):c.*216T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0827 in 448,958 control chromosomes in the GnomAD database, including 2,492 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.080 ( 711 hom., cov: 33)
Exomes 𝑓: 0.084 ( 1781 hom. )
Consequence
CACNA1E
NM_001205293.3 3_prime_UTR
NM_001205293.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.345
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 1-181799050-T-C is Benign according to our data. Variant chr1-181799050-T-C is described in ClinVar as [Benign]. Clinvar id is 1228100.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.276 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1E | NM_001205293.3 | c.*216T>C | 3_prime_UTR_variant | 48/48 | ENST00000367573.7 | NP_001192222.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1E | ENST00000367573.7 | c.*216T>C | 3_prime_UTR_variant | 48/48 | 1 | NM_001205293.3 | ENSP00000356545.2 | |||
CACNA1E | ENST00000367570.6 | c.*216T>C | 3_prime_UTR_variant | 47/47 | 1 | ENSP00000356542.1 | ||||
CACNA1E | ENST00000621791.4 | c.*216T>C | 3_prime_UTR_variant | 46/46 | 1 | ENSP00000481619.1 | ||||
CACNA1E | ENST00000700190.1 | c.498+2192T>C | intron_variant | ENSP00000514852.1 |
Frequencies
GnomAD3 genomes AF: 0.0802 AC: 12203AN: 152164Hom.: 706 Cov.: 33
GnomAD3 genomes
AF:
AC:
12203
AN:
152164
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0840 AC: 24932AN: 296676Hom.: 1781 Cov.: 4 AF XY: 0.0844 AC XY: 12737AN XY: 150888
GnomAD4 exome
AF:
AC:
24932
AN:
296676
Hom.:
Cov.:
4
AF XY:
AC XY:
12737
AN XY:
150888
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0801 AC: 12203AN: 152282Hom.: 711 Cov.: 33 AF XY: 0.0851 AC XY: 6339AN XY: 74454
GnomAD4 genome
AF:
AC:
12203
AN:
152282
Hom.:
Cov.:
33
AF XY:
AC XY:
6339
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
624
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 15, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at